Tg Therapeutics (TGTX) Assets Average (2011 - 2026)

Tg Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Assets Average rose 109.99% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 109.99% YoY), while the FY2025 annual figure was $820.5 million, up 80.86% from the prior year.
• Assets Average was $1.3 billion for Q1 2026 at Tg Therapeutics, up from $1.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.3 billion in Q1 2026 to a low of $195.5 million in Q1 2023.
• Historically, Assets Average has averaged $493.2 million across 5 years, with a median of $351.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Assets Average tumbled 47.87% in 2022, then surged 109.99% in 2026.
• A 5-year view of Assets Average shows it stood at $205.7 million in 2022, then soared by 60.56% to $330.3 million in 2023, then soared by 76.14% to $581.9 million in 2024, then surged by 79.45% to $1.0 billion in 2025, then rose by 24.13% to $1.3 billion in 2026.
• The last three Assets Average figures came in at $1.3 billion (Q1 2026), $1.0 billion (Q4 2025), and $863.8 million (Q3 2025), per Business Quant data.